Tandem autologous-haploidentical transplantation is a feasible and effective program for refractory Hodgkin lymphoma-Reference-Cited by-同舟云学术

Tandem autologous-haploidentical transplantation is a feasible and effective program for refractory Hodgkin lymphoma

Published:2017-12-21 Issue:3 Volume:53 Page:366-370
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Mariotti Jacopo,Bramanti Stefania,Devillier Raynier,Furst Sabine,El Cheikh Jean^ORCID,Sarina Barbara,Granata Angela,Faucher Catherine,Harbi Samia,Morabito Lucio,Weiller Pierre Jean,Chabannon Christian^ORCID,Mokart Jamel,Mineri Rossana,Carlo-Stella Carmelo,Santoro Armando,Blaise Didier,Castagna Luca^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/s41409-017-0032-1.pdf

Reference18 articles.

1. von Tresckow B, Engert A. The role of autologous transplantation in Hodgkin lymphoma. Curr Hematol Malig Rep. 2011;6:172–9.

2. Hahn T, McCarthy PL, Carreras J, Zhang MJ, Lazarus HM, Laport GG, et al. Simplified validated prognostic model for progression-free survival after autologous transplantation for hodgkin lymphoma. Biol Blood Marrow Transplant. 2013;19:1740–4.

3. Sureda A, Constans M, Iriondo A, Arranz R, Caballero MD, Vidal MJ, et al. Prognostic factors affecting long-term outcome after stem cell transplantation in Hodgkin’s lymphoma autografted after a first relapse. Ann Oncol. 2005;16:625–33.

4. Younes A, Gopal AK, Smith SE, Ansell SM, Rosenblatt JD, Savage KJ, et al. Results of a pivotal phase II study of brentuximab vedotin for patients with relapsed or refractory Hodgkin’s lymphoma. J Clin Oncol. 2012;30:2183–9.

5. Chen R, Gopal AK, Smith SE, Ansell SM, Rosenblatt JD, Savage KJ, et al. Five-year survival and durability results of brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma. Blood. 2016;128:1562–6.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcome of High-Dose Chemotherapy Followed by Autologous Stem Cell Transplantation in Relapsed/Refractory Hodgkin Lymphoma after Different Numbers of Salvage Regimens;Cells;2024-01-09

2. Advances in the treatment of Hodgkin lymphoma: Current and future approaches;Frontiers in Oncology;2023-03-03

3. Tandem autologous-reduced intensity allogeneic stem cell transplantation in high-risk relapsed Hodgkin lymphoma: a retrospective study of the Lymphoma Working Party—EBMT;Bone Marrow Transplantation;2020-10-12